Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small‐molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids
出版年份 2021 全文链接
标题
Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small‐molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids
作者
关键词
-
出版物
JOURNAL OF NANOBIOTECHNOLOGY
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-03-08
DOI
10.1186/s12951-021-00781-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A promising approach to develop nanostructured lipid carriers from solid lipid nanoparticles: preparation, characterization, cytotoxicity and nucleic acid binding ability
- (2020) Ezgi Oner et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets
- (2019) Juan Bayo et al. JOURNAL OF HEPATOLOGY
- Rapid quantification of cellular proliferation and migration using ImageJ
- (2019) C Venter et al. BIOTECHNIQUES
- Lipid-Based DNA Therapeutics – Hallmarks of Non-Viral Gene Delivery
- (2019) Jonas Buck et al. ACS Nano
- ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2
- (2019) Romain Lévêque et al. CANCER LETTERS
- Efficient nanocarriers of siRNA therapeutics for cancer treatment
- (2019) Md Abdus Subhan et al. Translational Research
- Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells
- (2019) Massimo Romani et al. Cancers
- Lipid-based nanocarriers for delivery of small interfering RNA for therapeutic use
- (2019) Deepti Parashar et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Oligonucleotides to the (Gene) Rescue: FDA Approvals 2017–2019
- (2019) Jacqueline Rüger et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Androgen receptor-independent prostate cancer: an emerging clinical entity
- (2018) Ilyas Sahin et al. CANCER BIOLOGY & THERAPY
- KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance
- (2018) Wenxia Xu et al. International Journal of Biological Sciences
- EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma
- (2018) Silvia Garcia-Monclús et al. INTERNATIONAL JOURNAL OF CANCER
- Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer
- (2018) Hadas Gibori et al. Nature Communications
- JIB-04, A Small Molecule Histone Demethylase Inhibitor, Selectively Targets Colorectal Cancer Stem Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway
- (2018) Min Seong Kim et al. Scientific Reports
- Recent Advances in the Application of Vitamin E TPGS for Drug Delivery
- (2018) Conglian Yang et al. Theranostics
- Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
- (2018) Kulmira Nurgali et al. Frontiers in Pharmacology
- Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
- (2018) Sigrid A. Langhans Frontiers in Pharmacology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- KDM5 demethylases and their role in cancer cell chemoresistance
- (2018) J. Plch et al. INTERNATIONAL JOURNAL OF CANCER
- The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
- (2018) Janet K. Parrish et al. Oncotarget
- Systematic Screening of Commonly Used Commercial Transfection Reagents towards Efficient Transfection of Single-Stranded Oligonucleotides
- (2018) Tao Wang et al. MOLECULES
- Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand Breaks
- (2018) Juan Bayo et al. Cell Reports
- Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)
- (2017) Michael J. Wagner et al. MOLECULAR CANCER THERAPEUTICS
- Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery
- (2017) M.C. Teixeira et al. PROGRESS IN LIPID RESEARCH
- Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells
- (2017) Barbara Banelli et al. Oncotarget
- Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
- (2017) Maithili P. Dalvi et al. Cell Reports
- Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1
- (2016) Tae-Dong Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Recent Progress in Histone Demethylase Inhibitors
- (2016) Tom E. McAllister et al. JOURNAL OF MEDICINAL CHEMISTRY
- HEDD: the human epigenetic drug database
- (2016) Yunfeng Qi et al. Database-The Journal of Biological Databases and Curation
- Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K
- (2016) Hua Wang et al. Journal of Cancer
- Preclinical and clinical development of siRNA-based therapeutics
- (2015) Gulnihal Ozcan et al. ADVANCED DRUG DELIVERY REVIEWS
- Harnessing the potential of epigenetic therapy to target solid tumors
- (2014) Nita Ahuja et al. JOURNAL OF CLINICAL INVESTIGATION
- EphA2 enhances the proliferation and invasion ability of LNCaP prostate cancer cells
- (2014) PEIJIE CHEN et al. Oncology Letters
- KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells
- (2013) W. L. Berry et al. CANCER RESEARCH
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth
- (2013) Lei Wang et al. Nature Communications
- Rapid Generation of In Vitro Multicellular Spheroids for the Study of Monoclonal Antibody Therapy
- (2012) Yen T. Phung et al. Journal of Cancer
- EphA2 Induces Metastatic Growth Regulating Amoeboid Motility and Clonogenic Potential in Prostate Carcinoma Cells
- (2011) M. L. Taddei et al. MOLECULAR CANCER RESEARCH
- Epha2 is a critical oncogene in melanoma
- (2011) D Udayakumar et al. ONCOGENE
- Transfection Efficiency of Cationic Lipids with Different Hydrophobic Domains in Gene Delivery
- (2010) DeFu Zhi et al. BIOCONJUGATE CHEMISTRY
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Emerging strategies for EphA2 receptor targeting for cancer therapeutics
- (2010) Manish Tandon et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
- (2009) Hui Miao et al. CANCER CELL
- Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: Disulfide bonds boost intracellular release of the cargo
- (2008) Miriam Breunig et al. JOURNAL OF CONTROLLED RELEASE
- Potential of solid lipid nanoparticles in brain targeting
- (2008) Indu Pal Kaur et al. JOURNAL OF CONTROLLED RELEASE
- RNA interference targeting EphA2 inhibits proliferation, induces apoptosis, and cooperates with cytotoxic drugs in human glioma cells
- (2008) Zhangming Zhou et al. SURGICAL NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started